Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Parkinson's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00228150
What this trial is testing

Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Sanofi 564
Large-scale testing (Phase 3)Study completedNCT00599196
What this trial is testing

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease

Who this might be right for
Early Stage Parkinson's Disease
UCB Pharma 381
Not applicableStudy completedNCT01470859
What this trial is testing

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Huashan Hospital 30
Large-scale testing (Phase 3)Study completedNCT00643045
What this trial is testing

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist

Who this might be right for
Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA 269
Not applicableLooking for participantsNCT06665113
What this trial is testing

Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease, Idiopathic
Kezhong Zhang 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06816810
What this trial is testing

Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease

Who this might be right for
Parkinson&Amp;#39;s Disease
Ottawa Hospital Research Institute 40
Not applicableUnknownNCT03552861
What this trial is testing

Standardization and Optimization of TMS Protocols for the Treatment of PD With Depression or Cognitive Impairment

Who this might be right for
TMS Protocols in the Treatment of PD
Guangdong Provincial People's Hospital 252
Not applicableLooking for participantsNCT06161636
What this trial is testing

Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease

Who this might be right for
Parkinson DiseaseHealthyParkinsonian Syndromes
Centre hospitalier de l'Université de Montréal (CHUM) 90
Not applicableLooking for participantsNCT07752355
What this trial is testing

Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms

Who this might be right for
Young Onset Parkinson DiseaseParkinson Disease
NYU Langone Health 250
Testing effectiveness (Phase 2)Study completedNCT06006247
What this trial is testing

Early Parkinson's Disease Monotherapy With CVN424

Who this might be right for
Parkinson's Disease
Cerevance Beta, Inc. 64
Not applicableLooking for participantsNCT06193252
What this trial is testing

Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more
Radboud University Medical Center 110
Testing effectiveness (Phase 2)Study completedNCT04658186
What this trial is testing

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

Who this might be right for
Early-stage Parkinson's Disease
UCB Biopharma SRL 496
Not applicableUnknownNCT02524405
What this trial is testing

BEAM: Brain-Eye Amyloid Memory Study

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentVascular Cognitive Impairment+2 more
Sunnybrook Health Sciences Centre 345
Large-scale testing (Phase 3)Study completedNCT01556165
What this trial is testing

Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China

Who this might be right for
Parkinson's Disease
H. Lundbeck A/S 130
Not applicableStudy completedNCT02403765
What this trial is testing

Diagnostic Tools for Parkinson's Disease

Who this might be right for
Parkinson Disease
Neuromed IRCCS 500
Not applicableLooking for participantsNCT07227896
What this trial is testing

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

Who this might be right for
Parkinson's Disease
AbbVie 100
Very early researchNot Yet RecruitingNCT07214974
What this trial is testing

Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.

Who this might be right for
Mild Cognitive Impairment (MCI)Early Stages of Cognitive DeclineAlzheimer's Disease Dementia+7 more
Noah Tech, Corp. 600
Large-scale testing (Phase 3)Study completedNCT04978597
What this trial is testing

Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)

Who this might be right for
Parkinson
Bial - Portela C S.A. 410
Testing effectiveness (Phase 2)UnknownNCT04305002
What this trial is testing

Exenatide Treatment in Parkinson's Disease

Who this might be right for
Parkinson Disease
Center for Neurology, Stockholm 60
Not applicableLooking for participantsNCT03508960
What this trial is testing

Chinese EOPD Registry

Who this might be right for
Parkinson Disease
Xiangya Hospital of Central South University 3,000
Next Page